Cetuximab is a monoclonal antibody used to treat certain types of cancer. It is used to treat metastatic colorectal cancer, head and neck cancer, and metastatic non-small cell lung cancer. Cetuximab works by targeting a protein on the surface of cancer cells called epidermal growth factor receptor (EGFR). By blocking the activity of the EGFR, cetuximab can prevent cancer cells from growing and spreading.
Cetuximab: A Targeted Therapy for Specific Cancers
Cetuximab, sold under the brand name Erbitux, is a prescription medication classified as a monoclonal antibody. It's a targeted therapy used to treat specific types of epithelial cancers, which are cancers that arise from the cells that cover the surface of organs and tissues.
Function:
- Targets specific protein: Cetuximab works by specifically targeting a protein called epidermal growth factor receptor (EGFR). This protein plays a crucial role in the growth and survival of some cancer cells. By binding to EGFR, cetuximab blocks its activity, thereby slowing down or stopping the growth and spread of cancer cells.
Uses:
Cetuximab is specifically approved by the US Food and Drug Administration (FDA) for the treatment of the following:
- Colorectal cancer: In combination with other chemotherapy medications, for advanced or metastatic (cancer that has spread to other parts of the body) colorectal cancer with specific genetic mutations.
- Head and neck squamous cell carcinoma (HNSCC): In combination with radiation therapy or other chemotherapy medications, for recurrent or metastatic HNSCC.
Important Points:
- Not a first-line treatment: Cetuximab is typically used for advanced or metastatic cancer that has not responded well to other treatments.
- Genetic testing required: Before starting cetuximab, genetic testing is necessary to confirm the presence of the specific EGFR mutation that cetuximab targets.
- Potential side effects: Common side effects can include:
- Skin rash and acne-like eruptions
- Fatigue
- Diarrhea
- Nausea and vomiting
- Inflammation of the hair follicles (folliculitis)
- Infusion reactions (during administration)
- Close monitoring: Patients receiving cetuximab require close monitoring by a healthcare professional to manage side effects and assess treatment response.
Remember: This information is for general knowledge only and should not be a substitute for professional medical advice. Always consult with your doctor or healthcare provider regarding your specific condition, treatment options, and the potential risks and benefits of taking cetuximab. They can assess your individual needs and determine if cetuximab is an appropriate treatment option for you.